Key result
A 10 mmHg increase in systolic blood pressure was associated with increased cardiovascular mortality in nonfrail elderly patients with T2DM (HR 1.38; 95% CI 1.15-1.68) but not in frail patients.
Why the study?
Does frailty modify the relationship between blood pressure and mortality in elderly patients with type 2 diabetes?
Cohort (n=858)
Does frailty modify the relationship between blood pressure and mortality in elderly patients with type 2 diabetes?
Hazard Ratio: 1.38 (95% CI 1.15–1.68)
Frailty significantly modifies the prognostic impact of blood pressure in elderly patients with type 2 diabetes, with higher blood pressure predicting increased mortality in nonfrail patients but lower mortality in the oldest frail patients.
Suggests frailty-stratified BP assessment in elderly T2DM; hypothesis-generating for tailored targets pending RCTs.
OBJECTIVE: We aimed to investigate whether adjustment for frailty influences the relationship of blood pressure with mortality in elderly patients with type 2 diabetes mellitus (T2DM). METHODS: Patients aged 60 years and older (n = 858) were selected from a prospective observational cohort study of primary care patients with T2DM. Frailty was defined as a score less than 80 on the subscale 'physical functioning' of the RAND-36 questionnaire. After median follow-up for 14 years, multivariate Cox regression analyses were performed to evaluate the association between blood pressure and (cardiovascular) mortality. Analyses were performed in strata according to the frailty level ('physical functioning' score <80 and ≥80) and were repeated for patients older than 75 years. RESULTS: Frailty was highly prevalent in our study population; 629 out of 858 patients (73%) fulfilled the criterion. For patients aged at least 60 years, the hazard ratios (95% confidence interval) of a 10 mmHg increase in SBP and DBP for cardiovascular mortality in nonfrail patients were 1.38 (1.15-1.68%) and 1.60 (1.07-2.37%), respectively. No relationship was observed for frail patients. For the oldest frail elderly, the hazard ratios of SBP and DBP for all-cause mortality were 0.92 (0.87-0.98%) and 0.83 (0.73-0.93%), respectively. For the oldest nonfrail elderly, a positive relationship between SBP and all-cause mortality was observed. CONCLUSIONS: Frailty modifies the relationship between blood pressure and mortality in elderly patients with T2DM. Higher blood pressure was related to increased cardiovascular mortality in nonfrail patients, even in the oldest elderly, and to lower all-cause mortality in frail patients.
No takes yet. Share an insight, caveat, or question.
Hateren et al. (2015) conducted a cohort in Type 2 diabetes mellitus (n=858). Blood pressure (10 mmHg increase in SBP) was evaluated on Cardiovascular mortality (HR 1.38, 95% CI 1.15-1.68). A 10 mmHg increase in systolic blood pressure was associated with increased cardiovascular mortality in nonfrail elderly patients with T2DM (HR 1.38; 95% CI 1.15-1.68) but not in frail patients.